Sodium Bicarbonate → HCID 86609475, compound
Reaction equation
Cl.[F:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[CH:9]([N:14]1[CH2:19][CH2:18][C@@H:17]([SH:20])/[C:16](=[CH:21]/[C:22]2[CH:26]=[CH:25][N:24]([CH2:27][CH2:28][C:29]([O:31][CH2:32][CH3:33])=[O:30])[N:23]=2)/[CH2:15]1)[C:10]([O:12][CH3:13])=[O:11].C(=O)([O-])O.[Na+]>CC(O)C.CCCCCC>[F:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[C@H:9]([N:14]1[CH2:19][CH2:18][C@@H:17]([SH:20])/[C:16](=[CH:21]/[C:22]2[CH:26]=[CH:25][N:24]([CH2:27][CH2:28][C:29]([O:31][CH2:32][CH3:33])=[O:30])[N:23]=2)/[CH2:15]1)[C:10]([O:12][CH3:13])=[O:11]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
(4R)-(E)-1-[(1RS)-1-(2-Fluorophenyl)-2-methoxy-2-oxoethyl]-3-({1-[2-(ethoxycarbonyl)ethyl]-1H-pyrazol-3-yl}methylidene)-4-sulfanylpiperidine hydrochloride was treated with an aqueous sodium hydrogen carbonate solution. The liberated base was extracted with dichloromethane. The free base thus obtained (ca. 200 mg) was divided into five portions and subjected to preparative HPLC (Chiralcel OD-H, 20φ×250 mm, Daicel Chemical Industries Co., Ltd., eluent: 2-propanol/hexane=1/2, 4 ml/minute) to afford the more mobile isomer, (4R)-(E)-1-[(1S)-1-(2-fluorophenyl)-2-methoxy-2-oxoethyl]-3-({1-[2-(ethoxycarbonyl)ethyl]-1H-pyrazol-3-yl}methylidene)-4-sulfanylpiperidine (103.9 mg), and the less mobile isomer, (4R)-(E)-1-[(1R)-1-(2-fluorophenyl)-2-methoxy-2-oxoethyl]-3-({1-[2-(ethoxycarbonyl)ethyl]-1H-pyrazol-3-yl}methylidene)-4-sulfanylpiperidine (100.3 mg), both as colourless oils.
Workup
- extractionThe liberated base was extracted with dichloromethane
- customThe free base thus obtained (ca. 200 mg)
Sources & evidence
- ORD record
- ord-4622cd9b9b8f4ff385c2a75e1f5660a7
- Source dataset
- uspto-grants-2010_11
- Patent number
- US07829580B2
Reaction notes
Loading…